Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: A COMPERA analysis
Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, Stähler G, Grünig E, Held M, Ghofrani H, Claussen M, Lange T, Klose H, Rosenkranz S, Vonk-Noordegraaf A, Vizza C, Delcroix M, Opitz C, Pausch C, Scelsi L, Neurohr C, Olsson K, Coghlan J, Halank M, Skowasch D, Behr J, Milger K, Remppis B, Skride A, Jureviciene E, Gumbiene L, Miliauskas S, Löffler-Ragg J, Wilkens H, Pittrow D, Hoeper M, Ewert R
RHEUMATOLOGY. 2024;63(4):1139-1146.

Sex-specific Genetic Determinants of Right Ventricular Structure and Function
Harbaum L, Hennigs J, Pott J, Ostermann J, Sinning C, Sau A, Sieliwonczyk E, Ng F, Rhodes C, Tello K, Klose H, Gräf S, Wilkins M
AM J RESP CRIT CARE. 2024 [Epub ahead of print].

Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19
Pink I, Hennigs J, Ruhl L, Sauer A, Boblitz L, Huwe M, Fuge J, Falk C, Pietschmann T, de Zwaan M, Prasse A, Kluge S, Klose H, Hoeper M, Welte T
INFECTION. 2024;52(2):513-524.

Right ventricular strain to systolic pulmonary artery pressure ratio in response to treatment of pulmonary arterial hypertension
Pott J, Csengeri D, Ostermann J, Klose H, Sinning C, Harbaum L
ERJ OPEN RES. 2024;10(4):.

Pulmonale Hypertonie bei Lungenerkrankungen und/oder Hypoxie: Pathophysiologie, Diagnose, Prognose und Behandlung
Daher A, Klose H
DEUT MED WOCHENSCHR. 2023;148(23):1507-1513.

Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension
Dittrich A, Mienert J, Pott J, Engels L, Sinning C, Hennigs J, Klose H, Harbaum L
ERJ OPEN RES. 2023;9(2):.

Psychological risk factors for Long COVID and their modification: study protocol of a three-arm, randomised controlled trial (SOMA.COV)
Engelmann P, Büchel C, Frommhold J, Klose H, Lohse A, Maehder K, Nestoriuc Y, Scherer M, Suling A, Toussaint A, Weigel A, Zapf A, Löwe B
BJPSYCH OPEN. 2023;9(6):e207.

Gezielte medikamentöse Therapie der pulmonalarteriellen Hypertonie bei Patient*innen ohne Komorbiditäten
Klose H, Harbaum L, Richter M, Lichtblau M, Marra A, Kabitz H, Harutyunova S, Milger-Kneidinger K, Lange T
PNEUMOLOGIE. 2023;77(11):890-900.

Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential
Körbelin J, Matuszcak C, Runge J, Harbaum L, Klose H, Hennigs J
FRONT CARDIOVASC MED. 2023;9:1036096.

Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension
Ostermann J, Pott J, Hennigs J, Roedl K, Sinning C, Harbaum L, Klose H
ERJ OPEN RES. 2023;9(3):.

Nachweis einer hereditären hämorrhagischen Teleangiektasie (Morbus Osler) bei singulärer pulmonaler arteriovenöser Malformation
Schick-Bengardt X, Kachanov M, Bannas P, Galow S, Klose H, Woitschach R, Schönnagel B, Oqueka T
PNEUMOLOGIE. 2023;77(Suppl 01):S33.

Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis
Schmidt K, Milger K, Pausch C, Huscher D, Pittrow D, Grünig E, Staehler G, Gall H, Distler O, Skowasch D, Halank M, Wilkens H, Held M, Klose H, Hoeper M
EUR RESPIR J. 2023;61(4):.

Cutaneous and Mediastinal Emphysema Following Dental Cleaning
Buescher G, Klose H, Schultze A
DTSCH ARZTEBL INT. 2022;119(7):112.

Respiratory muscle dysfunction in long-COVID patients
Hennigs J, Huwe M, Hennigs A, Oqueka T, Simon M, Harbaum L, Körbelin J, Schmiedel S, Schulze Zur Wiesch J, Addo M, Kluge S, Klose H
INFECTION. 2022;50(5):1391-1397.

Organbezogene Folgeerscheinungen von COVID‑19 bei Erwachsenen
Hennigs J, Oqueka T, Harbaum L, Klose H
BUNDESGESUNDHEITSBLA. 2022;65(4):462-470.

Sarkoidose als Paradebeispiel einer granulomatösen Erkrankung
Oqueka T, Galow S, Simon M, Weidmann A, Stübiger N, Zengin-Sahm E, Sinning C, Krusche M, Ruffer N, Steurer S, Schick-Bengardt X, Sebode M, Horst L, Steinmetz O, Melderis S, Rosenkranz S, Möller K, Jantke H, Klose H
Z RHEUMATOL. 2022;81(7):535-548.

Das intimale Sarkom der Pulmonalarterie – Fallbericht einer seltenen Differenzialdiagnose der chronisch thromboembolischen pulmonalen Hypertonie
Pott J, Gräfin zu Reventlow P, Simon M, Steurer S, Harbaum L, Henes F, Klose H
PNEUMOLOGIE. 2022;76(9):633-638.

Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters
Yogeswaran A, Tello K, Lund J, Klose H, Harbaum L, Sommer N, Oqueka T, Hennigs J, Grimminger F, Seeger W, Ghofrani H, Richter M, Gall H
J HEART LUNG TRANSPL. 2022;41(3):400-410.

Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020
Brehm T, Heyer A, Roedl K, Jarczak D, Nierhaus A, Nentwich M, van der Meirschen M, Schultze A, Christner M, Fiedler W, Kröger N, Huber T, Klose H, Sterneck M, Jordan S, Kreuels B, Schmiedel S, Addo M, Huber S, Lohse A, Kluge S, Schulze Zur Wiesch J
J CLIN MED. 2021;10(11):.

Supportive care needs of patients with rare chronic diseases: multi-method, cross-sectional study
Depping M, Uhlenbusch N, von Kodolitsch Y, Klose H, Mautner V, Löwe B
ORPHANET J RARE DIS. 2021;16(1):44.

Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study
Harbaum L, Hennigs J, Simon M, Oqueka T, Watz H, Klose H
RESP RES. 2021;22(1):.

Granulomatosis with polyangiitis: mind the airway
Oqueka T, Klose H, Iking-Konert C, Schnoor U, Kluge S, Simon M
RESPIROL CASE REP. 2021;9(1):e00702.

Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension
Qaderi V, Weimann J, Harbaum L, Schrage B, Knappe D, Hennigs J, Sinning C, Schnabel R, Blankenberg S, Kirchhof P, Klose H, Magnussen C
J CLIN MED. 2021;10(21):.

Rätselhafte B-Symptomatik bei einem 61-Jährigen unter Therapie einer rheumatoiden Arthritis
Wüstenberg R, Christner M, Schmiedel S, Tariparast A, Wichmann D, Lennartz M, Klose H, Kluge S
INTERNIST. 2021;62(11):1231-1236.

Blood carbon dioxide tension and risk in pulmonary arterial hypertension
Harbaum L, Fuge J, Kamp J, Hennigs J, Simon M, Sinning C, Oqueka T, Grimminger J, Olsson K, Hoeper M, Klose H
INT J CARDIOL. 2020;318:131-137.

Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer
Hennigs J, Minner S, Tennstedt P, Löser R, Huland H, Klose H, Graefen M, Schlomm T, Sauter G, Bokemeyer C, Honecker F
SCI REP-UK. 2020;10(1):3250.

Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
Hoeper M, Pausch C, Grünig E, Klose H, Staehler G, Huscher D, Pittrow D, Olsson K, Vizza C, Gall H, Benjamin N, Distler O, Opitz C, Gibbs J, Delcroix M, Ghofrani H, Rosenkranz S, Ewert R, Kaemmerer H, Lange T, Kabitz H, Skowasch D, Skride A, Jureviciene E, Paleviciute E, Miliauskas S, Claussen M, Behr J, Milger K, Halank M, Wilkens H, Wirtz H, Pfeuffer-Jovic E, Harbaum L, Scholtz W, Dumitrescu D, Bruch L, Coghlan G, Neurohr C, Tsangaris I, Gorenflo M, Scelsi L, Vonk-Noordegraaf A, Ulrich S, Held M
J HEART LUNG TRANSPL. 2020;39(12):1435-1444.

Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study
Yogeswaran A, Gall H, Tello K, Grünig E, Xanthouli P, Ewert R, Kamp J, Olsson K, Wißmüller M, Rosenkranz S, Klose H, Harbaum L, Lange T, Opitz C, Waelde A, Milger K, Sommer N, Seeger W, Ghofrani H, Richter M
PULM CIRC. 2020;10(3):2045894020941682.

Case Report: Apixaban - Behandlung venöser Thrombembolien und Rezidivprophylaxe
Galow S, Klose H
Case Report. 2019;11(Heft 11):6-7.

The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertension
Hennigs J, Lüneburg N, Stage A, Schmitz M, Körbelin J, Harbaum L, Matuszcak C, Mienert J, Bokemeyer C, Böger R, Kiefmann R, Klose H
PURINERG SIGNAL. 2019;15(3):299-311.

High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening Biomarkers
Rossi A, Voigtländer M, Klose H, Schlüter H, Schön G, Loges S, Paolini M, Bokemeyer C, Reck M, Tarro G, Binder M
J ONCOL. 2019;2019:8970645.

Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase
Klinke A, Berghausen E, Friedrichs K, Molz S, Lau D, Remane L, Berlin M, Kaltwasser C, Adam M, Mehrkens D, Mollenhauer M, Manchanda K, Ravekes T, Heresi G, Aytekin M, Dweik R, Hennigs J, Kubala L, Michaëlsson E, Rosenkranz S, Rudolph T, Hazen S, Klose H, Schermuly R, Rudolph V, Baldus S
JCI INSIGHT. 2018;3(11):.

Endoscopic lung volume reduction coil treatment in patients with very low FEV: an observational study
Simon M, Harbaum L, Oqueka T, Kluge S, Klose H
THER ADV RESPIR DIS. 2018;12:1-10.

Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension
Sinning C, Harbaum L, Schrage B, Rübsamen N, Magnussen C, Waschki B, Kleemann W, Baaske K, Kögler M, Ojeda F, Fischer C, Benjamin N, Westermann D, Zengin E, Schäfer U, Egenlauf B, Klose H, Blankenberg S, Grünig E
RESPIRATION. 2018;96(3):249-258.

Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension
Harbaum L, Baaske K, Simon M, Oqueka T, Sinning C, Glatzel A, Lüneburg N, Sydow K, Bokemeyer C, Klose H
BMC PULM MED. 2017;17(1):72.

Monitoring und Individualisierung von körperlichem Training bei Patienten mit pulmonaler Hypertonie
Harbaum L, Grimminger J, Galow S, Grünig E, Klose H, Hennigs J
PNEUMOLOGE. 2017;14(4):237-243.

The Diagnosis and Treatment of Hemoptysis
Ittrich H, Bockhorn M, Klose H, Simon M
DTSCH ARZTEBL INT. 2017;114(21):371-381.

Endoscopic lung volume reduction coil treatment in patients with chronic hypercapnic respiratory failure: an observational study
Simon M, Harbaum L, Oqueka T, Kluge S, Klose H
THER ADV RESPIR DIS. 2017;11(1):9-19.

COPD-associated pulmonary Hypertension: clinical implications and current methods for treatment
Grimminger J, Ghofrani H, Weissmann N, Klose H, Grimminger F
EXPERT REV RESP MED. 2016;10(7):755-66.

Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension
Harbaum L, Renk E, Yousef S, Glatzel A, Lüneburg N, Hennigs J, Oqueka T, Baumann H, Atanackovic D, Grünig E, Böger R, Bokemeyer C, Klose H
BMC PULM MED. 2016;16(1):145.

Aktuelle Evidenz bei pulmonal arterieller Hypertonie: Diagnose- und Therapieleitfaden
Klose H, Hennigs J, Harbaum L, Simon M, Oqueka T, Sydow K
2016. Aktuelle Evidenz bei pulmonal arterieller Hypertonie . Klose H (Hrsg.). 3. Aufl. 1-68.

Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?
Lüneburg N, Siques P, Brito J, Arriaza K, Pena E, Klose H, Leon-Velarde F, Böger R
Pulmonary medicine. 2016;2016:6578578.

Wertigkeit der thorakalen Computertomografie in der Behandlung von Patienten mit ARDS
Simon M, Braune S, Quitzke A, Metschke M, Berliner C, Kalsow M, Klose H, Kluge S
PNEUMOLOGIE. 2016;70(S 01):P90.

Bleeding Complications After Endoscopic Lung Volume Reduction Coil Treatment: A Retrospective Observational Study
Simon M, Ittrich H, Harbaum L, Oqueka T, Kluge S, Klose H
ARCH BRONCONEUMOL. 2016;52(12):590-595.

Right heart failure in pregnant women with cyanotic congenital heart disease - The good, the bad and the ugly
Zengin E, Sinning C, Schrage B, Mueller G, Klose H, Sachweh J, Goepfert M, Hueneke B, Blankenberg S, Kozlik-Feldmann R
INT J CARDIOL. 2016;202:773-775.

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial
Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R, Uiker S, Halank M, Olsson K, Seeger W, Gall H, Rosenkranz S, Wilkens H, Mertens D, Seyfarth H, Opitz C, Ulrich S, Egenlauf B, Grünig E
EUR HEART J. 2015;37(1):35-44.

Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
Frost A, Barst R, Hoeper M, Chang H, Frantz R, Fukumoto Y, Galié N, Hassoun P, Klose H, Matsubara H, Morrell N, Peacock A, Pfeifer M, Simonneau G, Tapson V, Torres F, Dario Vizza C, Lawrence D, Yang W, Felser J, Quinn D, Ghofrani H
J HEART LUNG TRANSPL. 2015;34(11):1366-75.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè N, Barberà J, Frost A, Ghofrani H, Hoeper M, McLaughlin V, Peacock A, Simonneau G, Vachiery J, Grünig E, Oudiz R, Vonk-Noordegraaf A, White R, Blair C, Gillies H, Miller K, Harris J, Langley J, Rubin L
NEW ENGL J MED. 2015;373(9):834-44.

Medikamentöse Therapie der pulmonal arteriellen Hypertonie
Harbaum L, Olschewski H, Klose H
PNEUMOLOGE. 2015;12(5):390-400.

Does Circulating IL-17 Identify a Subset of Patients With Idiopathic Pulmonary Arterial Hypertension?
Harbaum L, Oqueka T, Glatzel A, Hennigs J, Lüneburg N, Klose H
CHEST. 2015;148(4):e131-2.

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
Hoeper M, Behr J, Held M, Grunig E, Vizza C, Vonk-Noordegraaf A, Lange T, Claussen M, Grohé C, Klose H, Olsson K, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs J
PLOS ONE. 2015;10(12):Art. e0141911.

Radiologic Management of Haemoptysis: Diagnostic and Interventional Bronchial Arterial Embolisation
Ittrich H, Klose H, Adam G
ROFO-FORTSCHR RONTG. 2015;187(4):248-259.

Therapie der pulmonal arteriellen Hypertonie
Klose H, Harbaum L, Oqueka T, Simon M, Grünig E
PNEUMOLOGIE. 2015;69(8):483-93; quiz 494-5.

MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH
Kolditz M, Seyfarth H, Wilkens H, Ewert R, Bollmann T, Dinter C, Hertel S, Klose H, Opitz C, Grünig E, Höffken G, Halank M
LUNG. 2015;193(6):901-10.

Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension
Wellbrock J, Harbaum L, Stamm H, Hennigs J, Schulz B, Klose H, Bokemeyer C, Fiedler W, Lüneburg N
LUNG. 2015.

Economic evaluation of exercise training in patients with pulmonary hypertension
Ehlken N, Verduyn C, Tiede H, Staehler G, Karger G, Nechwatal R, Opitz C, Klose H, Wilkens H, Rosenkranz S, Halank M, Grünig E
LUNG. 2014;192(3):359-66.

DACH-Konferenz zur pulmonalen Hypertonie 2014
Grünig E, Klose H
DEUT MED WOCHENSCHR. 2014;139(Suppl 4):S109-S110.

Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapy
Harbaum L, Hennigs J, Baumann H, Bokemeyer C, Olschewski H, Klose H
EUR RESPIR J. 2014;43(5):1513-5.

N-terminal pro-brain natriuretic Peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency
Harbaum L, Hennigs J, Baumann H, Lüneburg N, Griesch E, Bokemeyer C, Grünig E, Klose H
PLOS ONE. 2014;9(4):e94263.

Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension
Hennigs J, Baumann H, Lüneburg N, Quast G, Harbaum L, Heyckendorf J, Sydow K, Schulte-Hubbert B, Halank M, Klose H
SCI REP-UK. 2014;4:4808.

Einsatz von Imatinib bei Patienten mit Pulmonal Arterieller Hypertonie
Hoeper M, Opitz C, Olschewski H, Ulrich S, Speich R, Behr J, Halank M, Wilkens H, Klose H, Lange T, Grünig E, Seeger W, Ewert R, Borst M, Welte T, Rosenkranz S, Ghofrani H
DEUT MED WOCHENSCHR. 2014;139 Suppl 4:S151-4.

Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocol
Jensen W, Oechsle K, Baumann H, Mehnert A, Klose H, Bloch W, Bokemeyer C, Baumann F
CONTEMP CLIN TRIALS. 2014;37(1):120-8.

Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH)
Klose H, Opitz C, Bremer H, Ewert R, Bonderman D, Rosenkranz S, Seeger W, Schmeißer A, Harbaum L, Buerke M, Ghofrani H, Borst M, Leuchte H, Lange T, Behr J, Ulrich S, Lang I, Olschewski H, Gall H, Kabitz H, Kleber F, Held M, Hoeper M, Grünig E
DEUT MED WOCHENSCHR. 2014;139 Suppl 4:S142-50.

Epigenetik und Genetik der pulmonal arteriellen Hypertonie--neue Erkenntnisse der letzten Jahre
Kwapiszewska G, Viales R, Ehlken N, Eichstaedt C, Riemekasten G, Grünig G, Mäder I, Klose H, Hinderhofer K, Fischer C, Ulrich S, Grünig E, Olschewski A
DEUT MED WOCHENSCHR. 2014;139 Suppl 4:S111-5.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Olsson K, Delcroix M, Ghofrani H, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange T, Behr J, Klose H, Claussen M, Ewert R, Opitz C, Vizza C, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs J, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper M
CIRCULATION. 2014;129(1):57-65.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)"
Olsson K, Delcroix M, Ghofrani H, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange T, Behr J, Klose H, Claussen M, Ewert R, Opitz C, Vizza C, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs J, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper M
CIRCULATION. 2014;130(12):e110-2.

High-flow nasal cannula oxygen versus non-invasive ventilation in patients with acute hypoxaemic respiratory failure undergoing flexible bronchoscopy - a prospective randomised trial
Simon M, Braune S, Frings D, Wiontzek A, Klose H, Kluge S
CRIT CARE. 2014;18(6):712.

55-jährige Patientin, Raucherin, mit deutlicher Abgeschlagenheit, Fieber und Hämoptysen
Thoennissen N, Clauditz T, Ittrich H, Stahl R, Bokemeyer C, Klose H
DEUT MED WOCHENSCHR. 2014;139(41):2073-4.

Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease
Becker-Grünig T, Klose H, Ehlken N, Lichtblau M, Nagel C, Fischer C, Gorenflo M, Tiede H, Schranz D, Hager A, Kaemmerer H, Miera O, Ulrich S, Speich R, Uiker S, Grünig E
INT J CARDIOL. 2013;168(1):375-81.

40-jähriger Patient mit Dyspnoe ein Jahr nach Lungentransplantation
Fuchs A, Klose H, Harbaum L, Kreuz J, Wilhelm K, Nickenig G, Skowasch D
DEUT MED WOCHENSCHR. 2013;138(21):1107-8.

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension
Ghofrani H, D'Armini A, Grimminger F, Hoeper M, Jansa P, Kim N, Mayer E, Simonneau G, Wilkins M, Fritsch A, Neuser D, Weimann G, Wang C
NEW ENGL J MED. 2013;369(4):319-29.

Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer
Grob T, Hoenig T, Clauditz T, Atanackovic D, Koenig A, Vashist Y, Klose H, Simon R, Pantel K, Izbicki J, Bokemeyer C, Sauter G, Wilczak W
LUNG CANCER. 2013;79(3):221-7.

Hamburger Netzwerk Pulmonale Hypertonie
Harbaum L, Hennigs J, Baumann H, Lüneburg N, Kluge S, Weil J, Sydow K, Klose H
Hamb Ärztebl. 2013;(10):26-28.

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Harzheim D, Klose H, Pinado F, Ehlken N, Nagel C, Fischer C, Ghofrani A, Rosenkranz S, Seyfarth H, Halank M, Mayer E, Grünig E, Guth S
RESP RES. 2013;14:104.

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry
Hoeper M, Huscher D, Ghofrani H, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange T, Behr J, Klose H, Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth H, Olsson K, Opitz C, Gaine S, Vizza C, Vonk-Noordegraaf A, Kaemmerer H, Gibbs J, Pittrow D
INT J CARDIOL. 2013;168(2):871-80.

Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension.
Ley S, Fink C, Risse F, Ehlken N, Fischer C, Ley-Zaporozhan J, Kauczor H, Klose H, Gruenig E
EUR RADIOL. 2013;23(2):324-331.

Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt.
Nistal M, Pace A, Klose H, Benten D, Lohse A
THORAX. 2013;68(9):889-890.

Macitentan and morbidity and mortality in pulmonary arterial hypertension
Pulido T, Adzerikho I, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Jing Z, Le Brun F, Mehta S, Mittelholzer C, Perchenet L, Sastry B, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin L, Simonneau G
NEW ENGL J MED. 2013;369(9):809-18.

Value of Computed Tomography of the Chest in Subjects With ARDS: A Retrospective Observational Study
Simon M, Braune S, Laqmani A, Metschke M, Berliner C, Kalsow M, Klose H, Kluge S
RESP CARE. 2013.

Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial.
Baumann H, Kluge S, Rummel K, Klose H, Hennigs J, Schmoller T, Meyer A
RESP RES. 2012;13:86.

Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung.
Grob T, Kannengiesser I, Tsourlakis M, Atanackovic D, König A, Vashist Y, Klose H, Marx A, Koops S, Simon R, Izbicki J, Bokemeyer C, Sauter G, Wilczak W
MODERN PATHOL. 2012;25(12):1566-1573.

Safety and efficacy of exercise training in various forms of pulmonary hypertension.
Grünig E, Lichtblau M, Ehlken N, Ghofrani H, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth H, Klose H, Meyer A, Sorichter S, Wilkens H, Rosenkranz S, Opitz C, Leuchte H, Karger G, Speich R, Nagel C
EUR RESPIR J. 2012;40(1):84-92.

[Tracheal metastasis of a cutaneous malignant melanoma].
Ritzel R, Klose H, Habermann C
ROFO-FORTSCHR RONTG. 2012;184(8):742-743.

Fiber optic bronchoscopy in patients with acute hypoxemic respiratory failure requiring noninvasive ventilation--a feasibility study.
Baumann H, Klose H, Simon M, Ghadban T, Braune S, Hennigs J, Kluge S
CRIT CARE. 2011;15(4):179.

Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011.
Ghofrani H, Distler O, Gerhardt F, Gorenflo M, Grünig E, Haefeli W, Held M, Hoeper M, Kähler C, Kaemmerer H, Klose H, Köllner V, Kopp B, Mebus S, Meyer A, Miera O, Pittrow D, Riemekasten G, Rosenkranz S, Schranz D, Voswinckel R, Olschewski H
INT J CARDIOL. 2011;154 Suppl 1:20-33.

Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension.
Grünig E, Ehlken N, Ghofrani A, Staehler G, Meyer F, Juenger J, Opitz C, Klose H, Wilkens H, Rosenkranz S, Olschewski H, Halank M
RESPIRATION. 2011;81(5):394-401.

Klassifikation und Differentialdiagnose der pulmonalen Hypertonie
Hennigs J, Baumann H, Lüneburg N, Kluge S, Sydow K, Klose H
Atemwegs LungenKh. 2011;37:443-448.

Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysis.
Hennigs J, Baumann H, Schmiedel S, Tennstedt P, Sobottka I, Bokemeyer C, Kluge S, Klose H
LUNG. 2011;189(6):475-483.

Molecular basis of P2-receptor-mediated calcium signaling in activated pancreatic stellate cells.
Hennigs J, Seiz O, Spiro J, Berna M, Baumann H, Klose H, Pace A
PANCREAS. 2011;40(5):740-746.

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
Hennigs J, von Amsberg G, Baumann H, Honecker F, Kluge S, Bokemeyer C, Brümmendorf T, Klose H
BMC PULM MED. 2011;11:30.

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.
Knudsen L, Schurawlew A, Nickel N, Tiede H, Ghofrani H, Wilkens H, Ewert R, Halank M, Klose H, Bäzner C, Behr J, Hoeper M
BMC PULM MED. 2011;11:56.

Structural brain changes related to disease duration in patients with asthma.
Von Leupoldt A, Brassen S, Baumann H, Klose H, Büchel C
PLOS ONE. 2011;6(8):23739.

[Utility of invasive diagnostics in acute lung injury].
Baumann H, Meyer A, Klose H, Kluge S
PNEUMOLOGIE. 2010;64(8):488-495.

Der Stellenwert von aktiviertem Protein C und Immunglobulinen in der Sepsistherapie
Hennigs J, Baumann H, Klose H, Kluge S
Atemwegs LungenKh. 2010;36:405-412.

Pulmonary hypertension after ventriculoatrial shunt implantation.
Kluge S, Baumann H, Regelsberger J, Kehler U, Gliemroth J, Koziej B, Klose H, Meyer A
J NEUROSURG. 2010;113(6):1279-1283.

[Heart rate measurement for determination of training intensity in outpatient pulmonary sport groups]
Baumann H, Kluge S, Klose H, Hellweger A, Braumann K, Meyer A
PNEUMOLOGIE. 2009;63(2):72-77.

Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation.
Kluge S, Baumann H, Regelsberger J, Kehler U, Koziej B, Klose H, Greinert U, Kreymann K, Meyer A
RESPIRATION. 2009;78(1):30-35.

Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options.
Schrader J, Sterneck M, Klose H, Lohse A, Nashan B, Fischer L
TRANSPL INT. 2009.

Einfluss genetischer Modifikationen auf die pulmonale Infektion vonCF-Patienten
Simon M, Klose H
2009. UPDATE Mukoviscidose Band 2: pulmonale Infektionen. Thieme-Verlag Stuttgart: 67-69.

Dyspnea and pain share emotion-related brain network.
von Leupoldt A, Sommer-Blöchl T, Kegat S, Baumann H, Klose H, Dahme B, Büchel C
NEUROIMAGE. 2009.

Down Regulation of Insular Cortex Responses to Dyspnea and Pain in Asthma.
von Leupoldt A, Sommer-Blöchl T, Kegat S, Eippert F, Baumann H, Klose H, Dahme B, Büchel C
AM J RESP CRIT CARE. 2009.

Impairment of respiratory muscle function in pulmonary hypertension.
Kabitz H, Schwoerer A, Bremer H, Sonntag F, Walterspacher S, Walker D, Schaefer V, Ehlken N, Staehler G, Halank M, Klose H, Ghofrani H, Hoeper M, Gruenig E, Windisch W
CLIN SCI. 2008;114(2):165-171.

Tracheostomy in the intensive care unit: a nationwide survey.
Kluge S, Baumann H, Maier C, Klose H, Meyer A, Nierhaus A, Kreymann K
ANESTH ANALG. 2008;107(5):1639-1643.

The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala.
von Leupoldt A, Sommer-Blöchl T, Kegat S, Baumann H, Klose H, Dahme B, Büchel C
AM J RESP CRIT CARE. 2008;177(9):1026-1032.

[A role for combination therapy in pulmonary arterial hypertension]
Behr J, Borst M, Winkler J, Hoeper M, Halank M, Ghofrani A, Klose H, Wilkens H, Stähler G
PNEUMOLOGIE. 2005;59(10):730-735.

Spontaneous bacterial peritonitis due to Listeria monocytogenes in a patient with primary pulmonary hypertension.
Rohde H, Horstkotte M, Sobottka I, Klose H, Mack D
EUR J CLIN MICROBIOL. 2002;21(4):323-325.

Letzte Aktualisierung aus dem FIS: 30.10.2024 - 23:32 Uhr